Home » Topics » Regulatory

Regulatory
RSS

Terumo's autologous skeletal myoblast sheets approved in Japan for heart failure

Sep. 7, 2015

FDA approves Xuriden for hereditary orotic aciduria

Sep. 7, 2015

FDA approves Varubi for nausea and vomiting associated with cancer chemotherapy

Sep. 3, 2015

Kanuma becomes first approved treatment in E.U. for LAL-D

Sep. 1, 2015

ALK's house dust mite allergy immunotherapy approved in 11 European countries

Sep. 1, 2015

FDA approves Aptiom as monotherapy for partial-onset seizures

Aug. 31, 2015

Exelixis receives first regulatory approval of cobimetinib in Switzerland

Aug. 28, 2015

Tracleer approved in Japan for new digital ulcers in patients with systemic scleroderma

Aug. 26, 2015

Remicade approved in Japan for entero-Behcet's, neuro-Behcet's and vasculo-Behcet's disease

Aug. 25, 2015

Daiichi Sankyo announces Japanese approvals for supplementary indications

Aug. 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...